ModivCare, Inc. (NASDAQ:MODV ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Heath Sampson - CEO, President, Interim President, Modivcare Home & Director Conference Call Participants Pito Chickering - Deutsche Bank Mike Petusky - Barrington Research Operator Good day, everyone, and welcome to ModivCare's First Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note, this conference call is being recorded.
ModivCare (MODV) came out with a quarterly loss of $1.71 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.09 per share a year ago.
ModivCare Inc. (NASDAQ:MODV ) Q4 2024 Earnings Conference Call March 6, 2025 5:00 PM ET Company Participants Heath Sampson – President and Chief Executive Officer Barbara Gutierrez – Chief Financial Officer Conference Call Participants Megan Holton – Jefferies Pito Chickering – Deutsche Bank Lee Jagoda – CJS Securities Raj Kumar – Stephens Operator Good day everyone and welcome to Modiv's Fourth Quarter and Full Year 2024 Financial Results Conference Call. At this time all participants are in a listen-only mode.
ModivCare (MODV) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of a loss of $0.10 per share. This compares to earnings of $1.29 per share a year ago.
RADNOR, Pa., Feb. 28, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against ModivCare Inc. ("ModivCare") (NASDAQ: MODV) on behalf of those who purchased or otherwise acquired ModivCare securities between November 3, 2022, and September 15, 2024, inclusive (the "Class Period"). The lead plaintiff deadline is March 31, 2025. aAdsList.push('Article'); aAdsListSize.push([300, 250]); aAdsListCA.push(null); CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered ModivCare losses, you may CLICK HERE or copy and paste the following link into your browser: Click Here You can also contact attorney Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected]. DEFENDANTS' ALLEGED MISCONDUCT:The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company's business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) certain of the company's non-emergency medical transportation contracts, rather than mitigating the risks to cash flow as ModivCare asserted, actually negatively impacted its free cash flow; (2) contract renegotiations and pricing accommodations negatively impacted the company's adjusted EBITDA; (3) ModivCare had insufficient liquidity; and (4) as a result, Defendants' statements about the company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.THE LEAD PLAINTIFF PROCESS:ModivCare investors may, no later than March 31, 2025, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is usually the investor or small group of investors who have the largest financial interest and who are also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class and these attorneys, if approved by the court, are lead or class counsel. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.Kessler Topaz Meltzer & Check, LLP encourages ModivCare investors who have suffered significant losses to contact the firm directly to acquire more information.CLICK HERE TO SIGN UP FOR THE CASE OR GO TO: Click Here ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP: Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world. The firm has developed a global reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common goal: to protect investors, consumers, employees and others from fraud, abuse, misconduct and negligence by businesses and fiduciaries. The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com.CONTACT:Kessler Topaz Meltzer & Check, LLPJonathan Naji, Esq.(484) 270-1453280 King of Prussia RoadRadnor, PA [email protected] May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes. View original content to download multimedia:Click Here SOURCE Kessler Topaz Meltzer & Check, LLP
ModivCare (MODV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ModivCare Inc. ("ModivCare Inc.") (NASDAQ:MODV) concerning possible violations of federal securities laws. On September 12, 2024, ModivCare filed a press release on a Form 8-K.
NEW YORK, NY / ACCESSWIRE / January 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ModivCare Inc. ("ModivCare Inc.") (NASDAQ:MODV) concerning possible violations of federal securities laws. On September 12, 2024, ModivCare filed a press release on a Form 8-K.
NEW YORK, NY / ACCESSWIRE / January 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ModivCare Inc. ("ModivCare Inc.") (NASDAQ:MODV) concerning possible violations of federal securities laws. On September 12, 2024, ModivCare filed a press release on a Form 8-K.
NEW YORK, NY / ACCESSWIRE / January 13, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ModivCare Inc. ("ModivCare Inc.") (NASDAQ:MODV) concerning possible violations of federal securities laws. On September 12, 2024, ModivCare filed a press release on a Form 8-K.
NEW YORK, NY / ACCESSWIRE / January 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ModivCare Inc. ("ModivCare Inc.") (NASDAQ:MODV) concerning possible violations of federal securities laws. On September 12, 2024, ModivCare filed a press release on a Form 8-K.
NEW YORK, NY / ACCESSWIRE / January 9, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of ModivCare Inc. ("ModivCare Inc.") (NASDAQ:MODV) concerning possible violations of federal securities laws. On September 12, 2024, ModivCare filed a press release on a Form 8-K.